Tryp Therapeutics Inc

12:09 PM EST - Tryp Therapeutics Inc : Today announced the filing of two new provisional patent applications. One patent application, #63/405,786, is for the use of psilocybin for the treatment of patients with fibromyalgia and the other application, #63/375,305, expands the IP related to the Company’s development of TRP-8803. Tryp Therapeutics Inc shares C.TRYP are trading down one cent at $0.14.

Stocks in Play